Skip to main content
. 2020 Apr 25;6:52. doi: 10.1186/s40814-020-00594-1

Table 3.

Adverse events

Adverse Event(s) Rivaroxaban-related? (n=) Rivaroxaban discontinued? (n=)
Infectious (Influenza, respiratory tract, fever NYD, cellulitis, pneumosepsis, disseminated histoplasmosis, viral infection NOS) n=9 n=0 n=1
Gastrointestinal (Nausea, melena, colonoscopy, 20 lb weight gain, epigastric pain) n=8 n=2 n=1
Headache n=5 n=4 n=2
Dermatological (Rash, finger nodules, leg ulcer) n=4 n=1 n=2
Neurological (Peripheral neuropathy/CNS impairment NYD, Bell’s palsy) n=3 n=0 n=0
SLE flare (including class IV lupus nephritis) n=2 n=0 n=1
Other (Chest pain, broken tooth, right hip arthroplasty, back pain, depression, cough, post-thrombotic syndrome, felt unwell, joint pain, prostate cancer, hypertensive urgency, SOB NYD) n=10 n=0 n=2
Death (Pneumosepsis) n=1 n=0 N/A